Corrigendum: Case report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient - Wang, Sha-Sha; Wang, Fang; Zeng, Zhen; Gao, Fang; Liu, Huan-Huan; Wang, Hui-Na; Hu, Yi; Qin, Hai-Feng (Frontiers in Oncology, 2022)